Alport Syndrome Therapeutics: Ready for Prime-Time Players

Kohei Omachi, Jeffrey H. Miner

Research output: Contribution to journalShort surveypeer-review

6 Scopus citations

Abstract

Alport syndrome (AS), a rare disease of basement membrane type IV collagen, impacts the kidneys, ears, and eyes. In severe cases, kidney failure occurs during adolescence or early adulthood, so most research has focused on remedies for kidney dysfunction. Planned and ongoing clinical studies using targets and therapeutic approaches discussed herein provide new hope for AS patients. The outcomes of these trials could suggest new treatments for more common forms of chronic kidney disease (CKD), demonstrating the importance of focusing on treatments for rare diseases.

Original languageEnglish
Pages (from-to)803-806
Number of pages4
JournalTrends in Pharmacological Sciences
Volume40
Issue number11
DOIs
StatePublished - Nov 2019

Keywords

  • chronic kidney disease
  • collagen IV
  • glomerulus
  • hematuria

Fingerprint Dive into the research topics of 'Alport Syndrome Therapeutics: Ready for Prime-Time Players'. Together they form a unique fingerprint.

Cite this